Edwards Lifesciences Corp. (EW)

149.31
NYSE : Health Technology
Prev Close 149.31
Day Low/High 0.00 / 0.00
52 Wk Low/High 100.20 / 175.00
Avg Volume 1.54M
Exchange NYSE
Shares Outstanding 209.39M
Market Cap 30.45B
EPS 2.80
P/E Ratio 47.68
Div & Yield N.A. (N.A)

Latest News

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Edwards Lifesciences' Philanthropy Exceeds Every Heartbeat Matters Goal To Impact One Million Underserved People Ahead Of Schedule

Edwards Lifesciences' Philanthropy Exceeds Every Heartbeat Matters Goal To Impact One Million Underserved People Ahead Of Schedule

Cumulative work of 60 non-profit partners now expected to reach 1.5 million by 2020

3 Biotech Stocks Ready to Burn Up

3 Biotech Stocks Ready to Burn Up

Biotechs are known for wild tears. Investors, you'll want to consider these drug makers.

Edwards Lifesciences Reports Second Quarter Results

Edwards Lifesciences Reports Second Quarter Results

IRVINE, Calif., July 26, 2018 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended...

Edwards Comments On CMS Advisory Panel

Edwards Comments On CMS Advisory Panel

BALTIMORE, July 25, 2018 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today commented on the U.

IIROC Trading Halt - EW

IIROC Trading Halt - EW

VANCOUVER, July 17, 2018 /CNW/ - The following issues have been halted by IIROC: Company: East West Petroleum Corp.

Edwards Lifesciences To Host Earnings Conference Call On July 26, 2018

Edwards Lifesciences To Host Earnings Conference Call On July 26, 2018

IRVINE, Calif., July 12, 2018 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter...

Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR

Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR

IRVINE, Calif., June 28, 2018 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today commented on the announcement by the U.

Four Stocks Poised for Big Gains: Cramer's 'Off the Charts'

Four Stocks Poised for Big Gains: Cramer's 'Off the Charts'

From purses and parcels to steel, Jim Cramer and Rob Moreno parse the moves of four stocks that are poised for big moves higher.

Markets Shrug Off N. Korea: Cramer's 'Mad Money' Recap (Tuesday, June 12 2018)

Markets Shrug Off N. Korea: Cramer's 'Mad Money' Recap (Tuesday, June 12 2018)

Jim Cramer explains what U.S. markets are focusing on now that North Korean nuclear worries have faded.

Tech Alone Can't Save the Rally: Cramer's 'Mad Money' Recap (Tuesday 6/5/18)

Tech Alone Can't Save the Rally: Cramer's 'Mad Money' Recap (Tuesday 6/5/18)

Jim Cramer says the tech titans are leading the way, but out side of the tech sector, very few stocks are following.

Hasbro, Dropbox, Carlyle Group: 'Mad Money' Lightning Round

Hasbro, Dropbox, Carlyle Group: 'Mad Money' Lightning Round

Jim Cramer weighs in on Hasbro, Dropbox, Carlyle Group, Corning, Banco Santander, Goldman Sachs, Edwards Lifesciences, J. Jill and more.

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

Medical Device Stocks Could Be Gearing Up to Be Market Leaders

When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back

The crash of oil will only accelerate the move.

9 Stocks Poised to Change Direction: Guess Which Way UPS Is Headed?

9 Stocks Poised to Change Direction: Guess Which Way UPS Is Headed?

These well-known names are showing signs of either bullish or bearish reversal patterns.

Edwards Lifesciences Takes Over #37 Spot From Vertex Pharmaceuticals

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Edwards Lifesciences Corp has taken over the #37 spot from Vertex Pharmaceuticals, Inc. , according to ETF Channel.

Regions Financial, Edwards Lifesciences: 'Mad Money' Lightning Round

Regions Financial, Edwards Lifesciences: 'Mad Money' Lightning Round

Jim Cramer focuses on Regions Financial, Edwards Lifesciences, Align Technology, Applied Materials, Qualys, HEICO and more.

Not Thankful for Fridays: Cramer's 'Mad Money' Recap (Friday 4/20/18)

Not Thankful for Fridays: Cramer's 'Mad Money' Recap (Friday 4/20/18)

Jim Cramer says analysts and trade woes put a damper on buying ahead of the weekend. So let's get the game plan for next week.

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

Large-cap healthcare stocks, especially those in the medical technology sector, are one of the biggest losers in the recent market selloff.

Edwards Lifesciences Achieves #54 Analyst Rank, Surpassing Snap-On

Edwards Lifesciences Achieves #54 Analyst Rank, Surpassing Snap-On

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Edwards Lifesciences Corp has taken over the #54 spot from Snap-On, Inc. , according to ETF Channel.

TheStreet Quant Rating: A- (Buy)